Marty Makary’s Confirmation Hearing for FDA Commissioner Under Scrutiny

Dr. Marty Makary, nominated by President Trump for the role of FDA Commissioner, faced intense scrutiny during his confirmation hearing on March 6, 2025. Makary, a noted surgeon and public health expert, has been vocal about his views on abortion pills and vaccines, drawing both support and criticism from various quarters.

During the hearing, senators grilled Makary on his previous statements regarding the safety and regulation of abortion pills, as well as his stance on vaccine mandates. His association with Robert F. Kennedy Jr., a vocal critic of certain vaccine policies, also came under the spotlight. Critics argue that Makary's views could influence FDA policies in controversial directions, while supporters praise his commitment to reevaluating current health regulations.

The confirmation process is closely watched by pharmaceutical companies and public health advocates alike, as Makary's potential leadership could significantly impact the FDA's approach to drug approvals and health policies. His nomination is seen as part of Trump's broader strategy to overhaul the agency and align it with his administration's priorities.

• FDA
• Marty Makary
• Robert F. Kennedy Jr.
• Trump